Focused Ultrasound for Mild Cognitive Impairment

This trial aims to determine if a wearable ultrasound device, called ATTN201, can improve sleep and help clear brain waste linked to early Alzheimer's disease. It targets individuals with mild cognitive impairment (MCI) who have a buildup of amyloid protein in the brain. The trial compares focused ultrasound, which targets a specific brain area, to unfocused ultrasound, which does not. Participants must complete sleep assessments and memory tests and have a diagnosis of MCI and amyloid buildup. The trial investigates whether using the device is safe and if it affects memory and thinking abilities. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance future Alzheimer's treatments.

Research has shown that low-intensity focused ultrasound (LIFU) treatments, such as those tested with the ATTN201 device, are generally safe for individuals with mild memory problems. In earlier studies, participants reported no unwanted side effects. These studies targeted specific brain areas with ultrasound waves. Participants tolerated the focused ultrasound well, and researchers found it caused no harm. This makes it a promising option for improving brain function without significant risk.¹²³⁴⁵

Researchers are excited about focused ultrasound for mild cognitive impairment because it offers a non-invasive option that targets the brain directly. Unlike traditional medications that affect the entire body, this treatment uses a head-worn device to deliver low-intensity focused ultrasound specifically to the centromedian nucleus of the thalamus, potentially improving cognitive function more precisely. Additionally, because it doesn't rely on drugs, it may avoid some side effects associated with conventional treatments. The unfocused ultrasound acts as a control, ensuring the effects observed are due to the targeted stimulation, which helps validate this innovative approach.

Research has shown that focused ultrasound might help people with mild cognitive impairment (MCI). In studies, patients experienced slight improvements in memory and thinking skills after receiving low-intensity focused ultrasound treatment. This method is believed to strengthen connections in the brain and may help remove amyloid, a protein linked to Alzheimer's disease. In this trial, participants will receive either low-intensity focused ultrasound targeted to the centromedian nucleus of the thalamus (CMN) or unfocused ultrasound as a sham comparator. One study found that 62.5% of patients had better cognitive scores, and 87% had stable or improved movement skills. These findings suggest that focused ultrasound could be a promising treatment for MCI by targeting brain areas involved in memory and sleep.¹²³⁴⁶